サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1311469

世界の製薬CXO市場：考察と予測 (2029年まで)

Global Pharmaceutical CXO Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 125 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.98円
世界の製薬CXO市場：考察と予測 (2029年まで)
出版日: 2023年07月24日
発行: QYResearch
ページ情報: 英文 125 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、製薬CXO (Pharmaceutical CXO) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の製薬CXOの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • CRO
    • CMO
    • CDMO
  • 市場：用途別
    • 世界の製薬CXOの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Pharmaceutical Companies
    • Biotechnology Companies
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の製薬CXOの市場展望 (2018-2029)
  • 世界の製薬CXOの市場成長トレンド：地域別
    • 製薬CXO 市場規模：地域別: 2018 VS 2022 VS 2029
    • 製薬CXOの市場規模実績：地域別 (2018-2023)
    • 製薬CXOの市場規模予測：地域別 (2024-2029)
  • 製薬CXO 市場動向
    • 製薬CXO 業界動向
    • 製薬CXO 市場の促進要因
    • 製薬CXO 市場の課題
    • 製薬CXO 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 製薬CXO ：競合別
    • 世界の製薬CXOの収益：企業別 (2018-2023)
    • 世界の製薬CXOの収益シェア：企業別 (2018-2023)
  • 世界の製薬CXOの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 製薬CXO, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の製薬CXO 市場集中度
    • 世界の製薬CXO 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 製薬CXOの収益 2022
  • 世界の主要企業 製薬CXO 本社 および提供地域
  • 世界の主要企業 製薬CXO, 製品およびアプリケーション
  • 世界の主要企業 製薬CXO, 業界参入時期
  • M&A, 拡張計画

第4章 製薬CXO 内訳データ：タイプ別

  • 世界の製薬CXOの市場規模実績：タイプ別 (2018-2023)
  • 世界の製薬CXOの市場規模予測：タイプ別 (2024-2029)

第5章 製薬CXO 内訳データ：用途別

  • 世界の製薬CXOの市場規模実績：用途別 (2018-2023)
  • 世界の製薬CXOの市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の製薬CXO 市場規模 (2018-2029)
  • 北米の製薬CXO 市場規模：タイプ別
    • 北米の製薬CXO 市場規模：タイプ別 (2018-2023)
    • 北米の製薬CXO 市場規模：タイプ別 (2024-2029)
    • 北米の製薬CXOの市場シェア：タイプ別 (2018-2029)
  • 北米の製薬CXO 市場規模：用途別
    • 北米の製薬CXO 市場規模：用途別 (2018-2023)
    • 北米の製薬CXO 市場規模：用途別 (2024-2029)
    • 北米の製薬CXOの市場シェア：用途別 (2018-2029)
  • 北米の製薬CXO 市場規模：国別
    • 北米の製薬CXO 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の製薬CXO 市場規模：国別 (2018-2023)
    • 北米の製薬CXO 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の製薬CXO 市場規模 (2018-2029)
  • 欧州の製薬CXO 市場規模：タイプ別
    • 欧州の製薬CXO 市場規模：タイプ別 (2018-2023)
    • 欧州の製薬CXO 市場規模：タイプ別 (2024-2029)
    • 欧州の製薬CXOの市場シェア：タイプ別 (2018-2029)
  • 欧州の製薬CXO 市場規模：用途別
    • 欧州の製薬CXO 市場規模：用途別 (2018-2023)
    • 欧州の製薬CXO 市場規模：用途別 (2024-2029)
    • 欧州の製薬CXOの市場シェア：用途別 (2018-2029)
  • 欧州の製薬CXO 市場規模：国別
    • 欧州の製薬CXO 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の製薬CXO 市場規模：国別 (2018-2023)
    • 欧州の製薬CXO 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の製薬CXO 市場規模 (2018-2029)
  • 中国の製薬CXO 市場規模：タイプ別
    • 中国の製薬CXO 市場規模：タイプ別 (2018-2023)
    • 中国の製薬CXO 市場規模：タイプ別 (2024-2029)
    • 中国の製薬CXOの市場シェア：タイプ別 (2018-2029)
  • 中国の製薬CXO 市場規模：用途別
    • 中国の製薬CXO 市場規模：用途別 (2018-2023)
    • 中国の製薬CXO 市場規模：用途別 (2024-2029)
    • 中国の製薬CXOの市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 製薬CXO 市場規模 (2018-2029)
  • アジア地域 製薬CXO 市場規模：タイプ別
    • アジア地域 製薬CXO 市場規模：タイプ別 (2018-2023)
    • アジア地域 製薬CXO 市場規模：タイプ別 (2024-2029)
    • アジア地域 製薬CXOの市場シェア：タイプ別 (2018-2029)
  • アジア地域 製薬CXO 市場規模：用途別
    • アジア地域 製薬CXO 市場規模：用途別 (2018-2023)
    • アジア地域 製薬CXO 市場規模：用途別 (2024-2029)
    • アジア地域 製薬CXOの市場シェア：用途別 (2018-2029)
  • アジア地域 製薬CXO 市場規模：地域別
    • アジア地域 製薬CXO 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 製薬CXO 市場規模：地域別 (2018-2023)
    • アジア地域 製薬CXO 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 製薬CXO 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 製薬CXO 市場規模：タイプ別
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 製薬CXOの市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 製薬CXO 市場規模：用途別
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 製薬CXOの市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 製薬CXO 市場規模：国別
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 製薬CXO 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • WuXi AppTec
  • Tigermed
  • Charles River Laboratories
  • Pharmaron Inc
  • Labcorp Drug Development
  • Boehringer Ingelheim
  • GenScript
  • MabPlex International
  • Shanghai ChemPartner
  • Wuxi Biologics
  • Pharmablock
  • Jiuzhou Pharma
  • Asym Chemical
  • IQVIA
  • Syneos Health
  • Parexel
  • AGC Biologics
  • FUJIFILM Diosynth Biotechnologies
  • Patheon
  • Catalent
  • Lonza Group AG
  • Avid Bioservices
  • AbbVie

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Pharmaceutical CXO Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of CRO
  • Table 3. Key Players of CMO
  • Table 4. Key Players of CDMO
  • Table 5. Global Pharmaceutical CXO Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 6. Global Pharmaceutical CXO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 7. Global Pharmaceutical CXO Market Size by Region (2018-2023) & (US$ Million)
  • Table 8. Global Pharmaceutical CXO Market Share by Region (2018-2023)
  • Table 9. Global Pharmaceutical CXO Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 10. Global Pharmaceutical CXO Market Share by Region (2024-2029)
  • Table 11. Pharmaceutical CXO Market Trends
  • Table 12. Pharmaceutical CXO Market Drivers
  • Table 13. Pharmaceutical CXO Market Challenges
  • Table 14. Pharmaceutical CXO Market Restraints
  • Table 15. Global Pharmaceutical CXO Revenue by Players (2018-2023) & (US$ Million)
  • Table 16. Global Pharmaceutical CXO Revenue Share by Players (2018-2023)
  • Table 17. Global Top Pharmaceutical CXO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2022)
  • Table 18. Global Pharmaceutical CXO Industry Ranking 2021 VS 2022 VS 2023
  • Table 19. Global 5 Largest Players Market Share by Pharmaceutical CXO Revenue (CR5 and HHI) & (2018-2023)
  • Table 20. Global Key Players of Pharmaceutical CXO, Headquarters and Area Served
  • Table 21. Global Key Players of Pharmaceutical CXO, Product and Application
  • Table 22. Global Key Players of Pharmaceutical CXO, Product and Application
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 25. Global Pharmaceutical CXO Revenue Market Share by Type (2018-2023)
  • Table 26. Global Pharmaceutical CXO Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 27. Global Pharmaceutical CXO Revenue Market Share by Type (2024-2029)
  • Table 28. Global Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 29. Global Pharmaceutical CXO Revenue Share by Application (2018-2023)
  • Table 30. Global Pharmaceutical CXO Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 31. Global Pharmaceutical CXO Revenue Share by Application (2024-2029)
  • Table 32. North America Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 33. North America Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
  • Table 34. North America Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 35. North America Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
  • Table 36. North America Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 37. North America Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
  • Table 38. North America Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
  • Table 39. Europe Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 40. Europe Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
  • Table 41. Europe Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 42. Europe Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
  • Table 43. Europe Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 44. Europe Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
  • Table 45. Europe Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
  • Table 46. China Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 47. China Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
  • Table 48. China Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 49. China Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
  • Table 50. Asia Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 51. Asia Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
  • Table 52. Asia Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 53. Asia Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
  • Table 54. Asia Pharmaceutical CXO Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 55. Asia Pharmaceutical CXO Market Size by Region (2018-2023) & (US$ Million)
  • Table 56. Asia Pharmaceutical CXO Market Size by Region (2024-2029) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2018-2023) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Pharmaceutical CXO Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 62. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2018-2023) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2024-2029) & (US$ Million)
  • Table 64. WuXi AppTec Company Details
  • Table 65. WuXi AppTec Business Overview
  • Table 66. WuXi AppTec Pharmaceutical CXO Product
  • Table 67. WuXi AppTec Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 68. WuXi AppTec Recent Developments
  • Table 69. Tigermed Company Details
  • Table 70. Tigermed Business Overview
  • Table 71. Tigermed Pharmaceutical CXO Product
  • Table 72. Tigermed Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 73. Tigermed Recent Developments
  • Table 74. Charles River Laboratories Company Details
  • Table 75. Charles River Laboratories Business Overview
  • Table 76. Charles River Laboratories Pharmaceutical CXO Product
  • Table 77. Charles River Laboratories Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 78. Charles River Laboratories Recent Developments
  • Table 79. Pharmaron Inc Company Details
  • Table 80. Pharmaron Inc Business Overview
  • Table 81. Pharmaron Inc Pharmaceutical CXO Product
  • Table 82. Pharmaron Inc Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 83. Pharmaron Inc Recent Developments
  • Table 84. Labcorp Drug Development Company Details
  • Table 85. Labcorp Drug Development Business Overview
  • Table 86. Labcorp Drug Development Pharmaceutical CXO Product
  • Table 87. Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 88. Labcorp Drug Development Recent Developments
  • Table 89. Boehringer Ingelheim Company Details
  • Table 90. Boehringer Ingelheim Business Overview
  • Table 91. Boehringer Ingelheim Pharmaceutical CXO Product
  • Table 92. Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 93. Boehringer Ingelheim Recent Developments
  • Table 94. GenScript Company Details
  • Table 95. GenScript Business Overview
  • Table 96. GenScript Pharmaceutical CXO Product
  • Table 97. GenScript Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 98. GenScript Recent Developments
  • Table 99. MabPlex International Company Details
  • Table 100. MabPlex International Business Overview
  • Table 101. MabPlex International Pharmaceutical CXO Product
  • Table 102. MabPlex International Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 103. MabPlex International Recent Developments
  • Table 104. Shanghai ChemPartner Company Details
  • Table 105. Shanghai ChemPartner Business Overview
  • Table 106. Shanghai ChemPartner Pharmaceutical CXO Product
  • Table 107. Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 108. Shanghai ChemPartner Recent Developments
  • Table 109. Wuxi Biologics Company Details
  • Table 110. Wuxi Biologics Business Overview
  • Table 111. Wuxi Biologics Pharmaceutical CXO Product
  • Table 112. Wuxi Biologics Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 113. Wuxi Biologics Recent Developments
  • Table 114. Pharmablock Company Details
  • Table 115. Pharmablock Business Overview
  • Table 116. Pharmablock Pharmaceutical CXO Product
  • Table 117. Pharmablock Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 118. Pharmablock Recent Developments
  • Table 119. Jiuzhou Pharma Company Details
  • Table 120. Jiuzhou Pharma Business Overview
  • Table 121. Jiuzhou Pharma Pharmaceutical CXO Product
  • Table 122. Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 123. Jiuzhou Pharma Recent Developments
  • Table 124. Asym Chemical Company Details
  • Table 125. Asym Chemical Business Overview
  • Table 126. Asym Chemical Pharmaceutical CXO Product
  • Table 127. Asym Chemical Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 128. Asym Chemical Recent Developments
  • Table 129. IQVIA Company Details
  • Table 130. IQVIA Business Overview
  • Table 131. IQVIA Pharmaceutical CXO Product
  • Table 132. IQVIA Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 133. IQVIA Recent Developments
  • Table 134. Syneos Health Company Details
  • Table 135. Syneos Health Business Overview
  • Table 136. Syneos Health Pharmaceutical CXO Product
  • Table 137. Syneos Health Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 138. Syneos Health Recent Developments
  • Table 139. Parexel Company Details
  • Table 140. Parexel Business Overview
  • Table 141. Parexel Pharmaceutical CXO Product
  • Table 142. Parexel Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 143. Parexel Recent Developments
  • Table 144. AGC Biologics Company Details
  • Table 145. AGC Biologics Business Overview
  • Table 146. AGC Biologics Pharmaceutical CXO Product
  • Table 147. AGC Biologics Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 148. AGC Biologics Recent Developments
  • Table 149. FUJIFILM Diosynth Biotechnologies Company Details
  • Table 150. FUJIFILM Diosynth Biotechnologies Business Overview
  • Table 151. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product
  • Table 152. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 153. FUJIFILM Diosynth Biotechnologies Recent Developments
  • Table 154. Patheon Company Details
  • Table 155. Patheon Business Overview
  • Table 156. Patheon Pharmaceutical CXO Product
  • Table 157. Patheon Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 158. Patheon Recent Developments
  • Table 159. Catalent Company Details
  • Table 160. Catalent Business Overview
  • Table 161. Catalent Pharmaceutical CXO Product
  • Table 162. Catalent Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 163. Catalent Recent Developments
  • Table 164. Lonza Group AG Company Details
  • Table 165. Lonza Group AG Business Overview
  • Table 166. Lonza Group AG Pharmaceutical CXO Product
  • Table 167. Lonza Group AG Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 168. Lonza Group AG Recent Developments
  • Table 169. Avid Bioservices Company Details
  • Table 170. Avid Bioservices Business Overview
  • Table 171. Avid Bioservices Pharmaceutical CXO Product
  • Table 172. Avid Bioservices Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 173. Avid Bioservices Recent Developments
  • Table 174. AbbVie Company Details
  • Table 175. AbbVie Business Overview
  • Table 176. AbbVie Pharmaceutical CXO Product
  • Table 177. AbbVie Revenue in Pharmaceutical CXO Business (2018-2023) & (US$ Million)
  • Table 178. AbbVie Recent Developments
  • Table 179. Research Programs/Design for This Report
  • Table 180. Key Data Information from Secondary Sources
  • Table 181. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Pharmaceutical CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Pharmaceutical CXO Market Share by Type: 2022 VS 2029
  • Figure 3. CRO Features
  • Figure 4. CMO Features
  • Figure 5. CDMO Features
  • Figure 6. Global Pharmaceutical CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Pharmaceutical CXO Market Share by Application: 2022 VS 2029
  • Figure 8. Pharmaceutical Companies Case Studies
  • Figure 9. Biotechnology Companies Case Studies
  • Figure 10. Pharmaceutical CXO Report Years Considered
  • Figure 11. Global Pharmaceutical CXO Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 12. Global Pharmaceutical CXO Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Pharmaceutical CXO Market Share by Region: 2022 VS 2029
  • Figure 14. Global Pharmaceutical CXO Market Share by Players in 2022
  • Figure 15. Global Top Pharmaceutical CXO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CXO as of 2022)
  • Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CXO Revenue in 2022
  • Figure 17. North America Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 18. North America Pharmaceutical CXO Market Share by Type (2018-2029)
  • Figure 19. North America Pharmaceutical CXO Market Share by Application (2018-2029)
  • Figure 20. North America Pharmaceutical CXO Market Share by Country (2018-2029)
  • Figure 21. United States Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 22. Canada Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 23. Europe Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
  • Figure 24. Europe Pharmaceutical CXO Market Share by Type (2018-2029)
  • Figure 25. Europe Pharmaceutical CXO Market Share by Application (2018-2029)
  • Figure 26. Europe Pharmaceutical CXO Market Share by Country (2018-2029)
  • Figure 27. Germany Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 28. France Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 29. U.K. Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 30. Italy Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. Russia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. Nordic Countries Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. China Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
  • Figure 34. China Pharmaceutical CXO Market Share by Type (2018-2029)
  • Figure 35. China Pharmaceutical CXO Market Share by Application (2018-2029)
  • Figure 36. Asia Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. Asia Pharmaceutical CXO Market Share by Type (2018-2029)
  • Figure 38. Asia Pharmaceutical CXO Market Share by Application (2018-2029)
  • Figure 39. Asia Pharmaceutical CXO Market Share by Region (2018-2029)
  • Figure 40. Japan Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 41. South Korea Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 42. China Taiwan Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 43. Southeast Asia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. India Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. Australia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Middle East, Africa, and Latin America Pharmaceutical CXO Market Size YoY (2018-2029) & (US$ Million)
  • Figure 47. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Type (2018-2029)
  • Figure 48. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Application (2018-2029)
  • Figure 49. Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Country (2018-2029)
  • Figure 50. Brazil Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 51. Mexico Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 52. Turkey Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 53. Saudi Arabia Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Israel Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. GCC Countries Pharmaceutical CXO Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. WuXi AppTec Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 57. Tigermed Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 58. Charles River Laboratories Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 59. Pharmaron Inc Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 60. Labcorp Drug Development Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 61. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 62. GenScript Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 63. MabPlex International Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 64. Shanghai ChemPartner Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 65. Wuxi Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 66. Pharmablock Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 67. Jiuzhou Pharma Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 68. Asym Chemical Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 69. IQVIA Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 70. Syneos Health Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 71. Parexel Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 72. AGC Biologics Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 73. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 74. Patheon Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 75. Catalent Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 76. Lonza Group AG Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 77. Avid Bioservices Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 78. AbbVie Revenue Growth Rate in Pharmaceutical CXO Business (2018-2023)
  • Figure 79. Bottom-up and Top-down Approaches for This Report
  • Figure 80. Data Triangulation
  • Figure 81. Key Executives Interviewed
目次

This research report focuses on the Pharmaceutical CXO Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pharmaceutical CXO Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 CRO
    • 1.2.3 CMO
    • 1.2.4 CDMO
  • 1.3 Market by Application
    • 1.3.1 Global Pharmaceutical CXO Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Biotechnology Companies
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Pharmaceutical CXO Market Perspective (2018-2029)
  • 2.2 Global Pharmaceutical CXO Growth Trends by Region
    • 2.2.1 Pharmaceutical CXO Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Pharmaceutical CXO Historic Market Size by Region (2018-2023)
    • 2.2.3 Pharmaceutical CXO Forecasted Market Size by Region (2024-2029)
  • 2.3 Pharmaceutical CXO Market Dynamics
    • 2.3.1 Pharmaceutical CXO Industry Trends
    • 2.3.2 Pharmaceutical CXO Market Drivers
    • 2.3.3 Pharmaceutical CXO Market Challenges
    • 2.3.4 Pharmaceutical CXO Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Pharmaceutical CXO by Players
    • 3.1.1 Global Pharmaceutical CXO Revenue by Players (2018-2023)
    • 3.1.2 Global Pharmaceutical CXO Revenue Market Share by Players (2018-2023)
  • 3.2 Global Pharmaceutical CXO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Pharmaceutical CXO, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Pharmaceutical CXO Market Concentration Ratio
    • 3.4.1 Global Pharmaceutical CXO Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CXO Revenue in 2022
  • 3.5 Global Key Players of Pharmaceutical CXO Head office and Area Served
  • 3.6 Global Key Players of Pharmaceutical CXO, Product and Application
  • 3.7 Global Key Players of Pharmaceutical CXO, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical CXO Breakdown Data by Type

  • 4.1 Global Pharmaceutical CXO Historic Market Size by Type (2018-2023)
  • 4.2 Global Pharmaceutical CXO Forecasted Market Size by Type (2024-2029)

5 Pharmaceutical CXO Breakdown Data by Application

  • 5.1 Global Pharmaceutical CXO Historic Market Size by Application (2018-2023)
  • 5.2 Global Pharmaceutical CXO Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Pharmaceutical CXO Market Size (2018-2029)
  • 6.2 North America Pharmaceutical CXO Market Size by Type
    • 6.2.1 North America Pharmaceutical CXO Market Size by Type (2018-2023)
    • 6.2.2 North America Pharmaceutical CXO Market Size by Type (2024-2029)
    • 6.2.3 North America Pharmaceutical CXO Market Share by Type (2018-2029)
  • 6.3 North America Pharmaceutical CXO Market Size by Application
    • 6.3.1 North America Pharmaceutical CXO Market Size by Application (2018-2023)
    • 6.3.2 North America Pharmaceutical CXO Market Size by Application (2024-2029)
    • 6.3.3 North America Pharmaceutical CXO Market Share by Application (2018-2029)
  • 6.4 North America Pharmaceutical CXO Market Size by Country
    • 6.4.1 North America Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Pharmaceutical CXO Market Size by Country (2018-2023)
    • 6.4.3 North America Pharmaceutical CXO Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Pharmaceutical CXO Market Size (2018-2029)
  • 7.2 Europe Pharmaceutical CXO Market Size by Type
    • 7.2.1 Europe Pharmaceutical CXO Market Size by Type (2018-2023)
    • 7.2.2 Europe Pharmaceutical CXO Market Size by Type (2024-2029)
    • 7.2.3 Europe Pharmaceutical CXO Market Share by Type (2018-2029)
  • 7.3 Europe Pharmaceutical CXO Market Size by Application
    • 7.3.1 Europe Pharmaceutical CXO Market Size by Application (2018-2023)
    • 7.3.2 Europe Pharmaceutical CXO Market Size by Application (2024-2029)
    • 7.3.3 Europe Pharmaceutical CXO Market Share by Application (2018-2029)
  • 7.4 Europe Pharmaceutical CXO Market Size by Country
    • 7.4.1 Europe Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Pharmaceutical CXO Market Size by Country (2018-2023)
    • 7.4.3 Europe Pharmaceutical CXO Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Pharmaceutical CXO Market Size (2018-2029)
  • 8.2 China Pharmaceutical CXO Market Size by Type
    • 8.2.1 China Pharmaceutical CXO Market Size by Type (2018-2023)
    • 8.2.2 China Pharmaceutical CXO Market Size by Type (2024-2029)
    • 8.2.3 China Pharmaceutical CXO Market Share by Type (2018-2029)
  • 8.3 China Pharmaceutical CXO Market Size by Application
    • 8.3.1 China Pharmaceutical CXO Market Size by Application (2018-2023)
    • 8.3.2 China Pharmaceutical CXO Market Size by Application (2024-2029)
    • 8.3.3 China Pharmaceutical CXO Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Pharmaceutical CXO Market Size (2018-2029)
  • 9.2 Asia Pharmaceutical CXO Market Size by Type
    • 9.2.1 Asia Pharmaceutical CXO Market Size by Type (2018-2023)
    • 9.2.2 Asia Pharmaceutical CXO Market Size by Type (2024-2029)
    • 9.2.3 Asia Pharmaceutical CXO Market Share by Type (2018-2029)
  • 9.3 Asia Pharmaceutical CXO Market Size by Application
    • 9.3.1 Asia Pharmaceutical CXO Market Size by Application (2018-2023)
    • 9.3.2 Asia Pharmaceutical CXO Market Size by Application (2024-2029)
    • 9.3.3 Asia Pharmaceutical CXO Market Share by Application (2018-2029)
  • 9.4 Asia Pharmaceutical CXO Market Size by Region
    • 9.4.1 Asia Pharmaceutical CXO Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Pharmaceutical CXO Market Size by Region (2018-2023)
    • 9.4.3 Asia Pharmaceutical CXO Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Pharmaceutical CXO Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 WuXi AppTec
    • 11.1.1 WuXi AppTec Company Details
    • 11.1.2 WuXi AppTec Business Overview
    • 11.1.3 WuXi AppTec Pharmaceutical CXO Introduction
    • 11.1.4 WuXi AppTec Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.1.5 WuXi AppTec Recent Developments
  • 11.2 Tigermed
    • 11.2.1 Tigermed Company Details
    • 11.2.2 Tigermed Business Overview
    • 11.2.3 Tigermed Pharmaceutical CXO Introduction
    • 11.2.4 Tigermed Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.2.5 Tigermed Recent Developments
  • 11.3 Charles River Laboratories
    • 11.3.1 Charles River Laboratories Company Details
    • 11.3.2 Charles River Laboratories Business Overview
    • 11.3.3 Charles River Laboratories Pharmaceutical CXO Introduction
    • 11.3.4 Charles River Laboratories Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.3.5 Charles River Laboratories Recent Developments
  • 11.4 Pharmaron Inc
    • 11.4.1 Pharmaron Inc Company Details
    • 11.4.2 Pharmaron Inc Business Overview
    • 11.4.3 Pharmaron Inc Pharmaceutical CXO Introduction
    • 11.4.4 Pharmaron Inc Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.4.5 Pharmaron Inc Recent Developments
  • 11.5 Labcorp Drug Development
    • 11.5.1 Labcorp Drug Development Company Details
    • 11.5.2 Labcorp Drug Development Business Overview
    • 11.5.3 Labcorp Drug Development Pharmaceutical CXO Introduction
    • 11.5.4 Labcorp Drug Development Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.5.5 Labcorp Drug Development Recent Developments
  • 11.6 Boehringer Ingelheim
    • 11.6.1 Boehringer Ingelheim Company Details
    • 11.6.2 Boehringer Ingelheim Business Overview
    • 11.6.3 Boehringer Ingelheim Pharmaceutical CXO Introduction
    • 11.6.4 Boehringer Ingelheim Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.6.5 Boehringer Ingelheim Recent Developments
  • 11.7 GenScript
    • 11.7.1 GenScript Company Details
    • 11.7.2 GenScript Business Overview
    • 11.7.3 GenScript Pharmaceutical CXO Introduction
    • 11.7.4 GenScript Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.7.5 GenScript Recent Developments
  • 11.8 MabPlex International
    • 11.8.1 MabPlex International Company Details
    • 11.8.2 MabPlex International Business Overview
    • 11.8.3 MabPlex International Pharmaceutical CXO Introduction
    • 11.8.4 MabPlex International Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.8.5 MabPlex International Recent Developments
  • 11.9 Shanghai ChemPartner
    • 11.9.1 Shanghai ChemPartner Company Details
    • 11.9.2 Shanghai ChemPartner Business Overview
    • 11.9.3 Shanghai ChemPartner Pharmaceutical CXO Introduction
    • 11.9.4 Shanghai ChemPartner Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.9.5 Shanghai ChemPartner Recent Developments
  • 11.10 Wuxi Biologics
    • 11.10.1 Wuxi Biologics Company Details
    • 11.10.2 Wuxi Biologics Business Overview
    • 11.10.3 Wuxi Biologics Pharmaceutical CXO Introduction
    • 11.10.4 Wuxi Biologics Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.10.5 Wuxi Biologics Recent Developments
  • 11.11 Pharmablock
    • 11.11.1 Pharmablock Company Details
    • 11.11.2 Pharmablock Business Overview
    • 11.11.3 Pharmablock Pharmaceutical CXO Introduction
    • 11.11.4 Pharmablock Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.11.5 Pharmablock Recent Developments
  • 11.12 Jiuzhou Pharma
    • 11.12.1 Jiuzhou Pharma Company Details
    • 11.12.2 Jiuzhou Pharma Business Overview
    • 11.12.3 Jiuzhou Pharma Pharmaceutical CXO Introduction
    • 11.12.4 Jiuzhou Pharma Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.12.5 Jiuzhou Pharma Recent Developments
  • 11.13 Asym Chemical
    • 11.13.1 Asym Chemical Company Details
    • 11.13.2 Asym Chemical Business Overview
    • 11.13.3 Asym Chemical Pharmaceutical CXO Introduction
    • 11.13.4 Asym Chemical Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.13.5 Asym Chemical Recent Developments
  • 11.14 IQVIA
    • 11.14.1 IQVIA Company Details
    • 11.14.2 IQVIA Business Overview
    • 11.14.3 IQVIA Pharmaceutical CXO Introduction
    • 11.14.4 IQVIA Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.14.5 IQVIA Recent Developments
  • 11.15 Syneos Health
    • 11.15.1 Syneos Health Company Details
    • 11.15.2 Syneos Health Business Overview
    • 11.15.3 Syneos Health Pharmaceutical CXO Introduction
    • 11.15.4 Syneos Health Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.15.5 Syneos Health Recent Developments
  • 11.16 Parexel
    • 11.16.1 Parexel Company Details
    • 11.16.2 Parexel Business Overview
    • 11.16.3 Parexel Pharmaceutical CXO Introduction
    • 11.16.4 Parexel Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.16.5 Parexel Recent Developments
  • 11.17 AGC Biologics
    • 11.17.1 AGC Biologics Company Details
    • 11.17.2 AGC Biologics Business Overview
    • 11.17.3 AGC Biologics Pharmaceutical CXO Introduction
    • 11.17.4 AGC Biologics Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.17.5 AGC Biologics Recent Developments
  • 11.18 FUJIFILM Diosynth Biotechnologies
    • 11.18.1 FUJIFILM Diosynth Biotechnologies Company Details
    • 11.18.2 FUJIFILM Diosynth Biotechnologies Business Overview
    • 11.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Introduction
    • 11.18.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.18.5 FUJIFILM Diosynth Biotechnologies Recent Developments
  • 11.19 Patheon
    • 11.19.1 Patheon Company Details
    • 11.19.2 Patheon Business Overview
    • 11.19.3 Patheon Pharmaceutical CXO Introduction
    • 11.19.4 Patheon Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.19.5 Patheon Recent Developments
  • 11.20 Catalent
    • 11.20.1 Catalent Company Details
    • 11.20.2 Catalent Business Overview
    • 11.20.3 Catalent Pharmaceutical CXO Introduction
    • 11.20.4 Catalent Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.20.5 Catalent Recent Developments
  • 11.21 Lonza Group AG
    • 11.21.1 Lonza Group AG Company Details
    • 11.21.2 Lonza Group AG Business Overview
    • 11.21.3 Lonza Group AG Pharmaceutical CXO Introduction
    • 11.21.4 Lonza Group AG Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.21.5 Lonza Group AG Recent Developments
  • 11.22 Avid Bioservices
    • 11.22.1 Avid Bioservices Company Details
    • 11.22.2 Avid Bioservices Business Overview
    • 11.22.3 Avid Bioservices Pharmaceutical CXO Introduction
    • 11.22.4 Avid Bioservices Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.22.5 Avid Bioservices Recent Developments
  • 11.23 AbbVie
    • 11.23.1 AbbVie Company Details
    • 11.23.2 AbbVie Business Overview
    • 11.23.3 AbbVie Pharmaceutical CXO Introduction
    • 11.23.4 AbbVie Revenue in Pharmaceutical CXO Business (2018-2023)
    • 11.23.5 AbbVie Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details